Old Saybrook, CT, United States of America

Michael E Perlman

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2005-2019

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Michael E Perlman: Innovator in Pharmaceutical Compositions

Introduction

Michael E Perlman is a notable inventor based in Old Saybrook, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance drug solubility and bioavailability. With a total of 3 patents to his name, Perlman's work has the potential to impact the way medications are formulated and administered.

Latest Patents

Among his latest patents, Perlman has developed pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials. This innovative composition comprises a solid amorphous dispersion that includes a low-solubility drug and a concentration-enhancing polymer, along with a lipophilic microphase-forming material. Alternatively, he has proposed that a solid amorphous dispersion can be co-administered with a lipophilic microphase-forming material to an in vivo use environment, which could significantly improve drug delivery systems.

Career Highlights

Throughout his career, Michael E Perlman has worked with prominent companies in the pharmaceutical industry, including Bend Research, Inc. and Pfizer Corporation. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research in drug formulation.

Collaborations

Perlman has had the opportunity to work alongside talented individuals such as Ravi Mysore Shanker and Walter Christian Babcock. These collaborations have further enriched his research and development efforts in the pharmaceutical field.

Conclusion

Michael E Perlman stands out as an innovative inventor whose work in pharmaceutical compositions is paving the way for advancements in drug delivery. His contributions are likely to have a lasting impact on the industry and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…